Offer - Urjas Oil for just ₹ 1 X
Kabidarba 25 Injection is a commercial drug that is prescribed in the form of Injection. Anemia are some of its major therapeutic uses.
The right dosage of Kabidarba 25 Injection depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Kabidarba 25 Injection as well, which are listed below. These side effects of Kabidarba 25 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Kabidarba 25 Injection's effect is Moderate during pregnancy and Unknown for lactating mothers. Warnings related to Kabidarba 25 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Kabidarba 25 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. High Blood Pressure, Heart Attack, Stroke are examples of such conditions. Other contraindications of Kabidarba 25 Injection have been discussed in the sections ahead.
Drug interactions for Kabidarba 25 Injection have been reported in the medical literature. See below for a complete list.
You should also be aware that Kabidarba 25 Injection is safe while driving, and is addiction.
Kabidarba 25 Injection is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Kabidarba 25 Injection safe for pregnant women?
Kabidarba may have some side effects during pregnancy. Pregnant women should discontinue the use of Kabidarba, and talk to their doctor, if they notice any discomfort.
Is the use of Kabidarba 25 Injection safe during breastfeeding?
In the absence of any scientific study about the side effects of Kabidarba in breastfeeding women, information on safety of Kabidarba is unavailable.
What is the effect of Kabidarba 25 Injection on the Kidneys?
Kabidarba has very mild side effects on the kidneys.
What is the effect of Kabidarba 25 Injection on the Liver?
You may experience side effects on your liver after taking Kabidarba. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Kabidarba 25 Injection on the Heart?
Kabidarba may have mild side effects on the heart. Most people will never see any effect on the heart.
Kabidarba 25 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Kabidarba 25 Injection unless your doctor advises you to do so -
Is this Kabidarba 25 Injection habit forming or addictive?
Kabidarba 25 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Kabidarba 25 Injection since it does not cause drowsiness.
Is it safe?
Yes, but take Kabidarba 25 Injection only as per medical advice.
Is it able to treat mental disorders?
No, Kabidarba 25 Injection cannot treat any kind of mental disorder.
Interaction between Food and Kabidarba 25 Injection
Information is not available on the interaction of any foods with Kabidarba 25 Injection, due to a lack of research on this.
Interaction between Alcohol and Kabidarba 25 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Kabidarba 25 Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aranesp® (darbepoetin alfa)